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The transcription factorPAX2 is expressedduringnormal kidney
development and is thought to influence outgrowth and branching
of the ureteric bud. Mice with homozygous null Pax2 mutations
havedevelopmental defects of themidbrain-hindbrain region, optic
nerve, and ear and are anephric. During nephrogenesis, PAX2 is
also expressed by mesenchymal cells as they cluster and reorganize
to form proximal elements of each nephron, but the function of
PAX2 in these cells is unknown. In this study we hypothesized that
PAX2 activates expression of WNT4, a secreted glycoprotein
known to be critical for successful nephrogenesis. PAX2 protein
was identified in distal portions of the “S-shaped” body, and the
protein persists in the emerging proximal tubules of murine fetal
kidney. PAX2 activatedWNT4 promoter activity 5-fold in co-trans-
fection assays with JTC12 cells derived from the proximal tubule.
Inspection of the 5-flanking sequence of the human WNT4 gene
identified three novel PAX2 recognitionmotifs; each exhibited spe-
cific PAX2 protein binding in electromobility shift assays. Two
motifs were contained within a completely duplicated 0.66-kb cas-
sette. Transfection of JTC12 cells with a PAX2 expression vector
was associated with a 7-fold increase in endogenousWNT4mRNA.
In contrast,Wnt4mRNAwasdecreasedby60% inmesenchymal cell
condensates of fetal kidney from mice with a heterozygous Pax2
mutation. We speculated that a key function of PAX2 is to activate
WNT4 gene expression in metanephric mesenchymal cells as they
differentiate to form elements of the renal tubules.
PAX2 belongs to the “paired box” family of transcription factors. Like
other family members, it is thought to orchestrate the patterns of gene
expression in specific cells during organ development. Homozygous
inactivation of the Pax2 gene in mice causes malformation of the mid-
brain-hindbrain region, the optic nerve, and complete absence of the
kidneys (1, 2). Although these observations clearly implicate PAX2 in
the development of renal and neural tissue, little is known about its
precise gene targets or the specific developmental processes in which it
plays a role.
Studies thus far suggest that the developmental functions of PAX2
may be multiplex, activating distinct panels of genes in different cell
lineages at different stages. During development of mammalian kidney,
PAX2 first appears during the caudal descent of the nephric duct where
it affects the fate of a cell (3). When the nephric duct arrives at about
somite 26, a “ureteric bud” (UB)2 emerges from its wall and grows
toward the adjacent lateral mesenchyme. This event is again orches-
trated by PAX2 through activation of glial cell line-derived neurotropic
Factor (GDNF) in the uninduced mesenchyme and activation of the
GDNF receptor (RET) in UB cells (4). Thus, homozygous Pax2 knock-
out mice lack normal ureteric bud outgrowth and are unable to induce
metanephric kidneys (2).
A third function of PAX2 in developing kidney involves suppression
of programmed cell death in ureteric bud cells. During normal develop-
ment, the UB arborizes as it penetrates the metanephric mesenchyme,
inducing nephrons to form at the tip of each branch. Final nephron
endowment is determined by the extent ofUBbranching achieved at the
point when new nephron formation comes to an end in the perinatal
period. Mice and humans lacking one Pax2 allele have increased apo-
ptosis of UB cells, reduced UB branching, and suboptimal final nephron
number (5, 6). Delivery of a pro-apoptotic gene (Bax) to the developing
UB reduces arborization (7); conversely, the branching defect seen in
Pax2 heterozygousmutants can be rescued by targeted expression of an
anti-apoptotic gene (Bcl2) to the UB lineage3 or by administration of
caspase inhibitors to pregnant mice bearing heterozygous mutant Pax2
fetuses (8).
Once within the mesenchyme, the arborizing UB delivers signals to
nearby mesenchymal cells, inducing them to cluster at the tip of each
UB branch. These induced mesenchymal cells express moderately high
levels of PAX2 as they undergo a profound transformation into polar-
ized epithelia, but the precise role of PAX2 during this process is
unknown (2). Rapid cell division and coordinated cell movement result
in twisting growth of an elongated “S-shaped” bodywith a central lumen
lined by epithelial cells. Capillary ingrowth at one end allows formation
of the glomerulus, and at its other end fusion with the UB branch tip
affords outflow of luminal fluid into the common collecting system.
Torban et al. (9) showed that PAX2 expression is associated with an
increase in E-cadherin and suppression of vimentin levels in cultured
fetal kidney cells, thus proposing that PAX2 might regulate the transi-
tion frommesenchyme to epithelium. However, the PAX2 gene targets
that might mediate this transition remain elusive.
In 1994, Stark et al. (10) reported that formation of S-shaped bodies in
the developing kidney is critically dependent on WNT4, a member of
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induced metanephric mesenchymal cells as they cluster and undergo
transformation into epithelia (10). Knock-out mice with homozygous
inactivation of the Wnt4 gene exhibit initial outgrowth of the ureteric
bud, induction of mesenchymal cell clustering, and local expression of
PAX2 but no further development of S-shaped bodies (10, 11). In the
absence of S-shaped body formation, UB branching comes to an abrupt
halt, and the mutant Wnt4 mice are born anephric (10). In general,
WNTs are thought to transmit signals to nearby cells bearing cognate
receptors, thereby organizing cell alignment and tissue patterns during
development (12). WNT4 was recently shown to be capable of activat-
ing the “canonical” -catenin signaling pathway and therefore presum-
ably regulates -catenin-responsive gene targets, such as c-Myc,
involved in cellular growth (13).
In this study, we hypothesize that a key function of PAX2 in the
S-shaped body is to activate theWNT4 gene. We show that PAX2 pro-
tein is present in the distal portion of the S-shaped body and persists in
the emerging proximal tubular cells of fetal kidney. Transient transfec-
tion of a PAX2 expression vector into JTC12 cells (derived from the
simian proximal tubule) stimulates transcriptional activity of the
humanWNT4 promoter.We identify several unique recognitionmotifs
in the WNT4 promoter that specifically bind PAX2 protein and show
that JTC12 cells stably transfected with PAX2 cDNA have increased
endogenous WNT4 expression. Finally, we demonstrate that endoge-
nous WNT4 expression is reduced in hypoplastic fetal kidneys of mice
bearing a heterozygous Pax2mutation.
MATERIALS ANDMETHODS
Cell Lines, Transfections, and Luciferase Assays—The monkey prox-
imal tubule cell line (JTC12) was grown in Dulbecco’s modified Eagle’s
medium supplemented with 10% heat-inactivated fetal bovine serum,
100 units/ml penicillin, 100 g/ml streptomycin. Cells were incubated
at 37 °C with 5% CO2 in a humidified environment. The activity of a
10.7-kbWNT4 promoter was analyzed in transient transfections of the
JTC12 cell line in the presence or absence of a PAX2 expression vector.
Plasmid DNA preparation, cell culture, and transient transfections
using FuGENETM 6 transfection reagent (Roche Applied Science) were
carried out as described (14), with modifications. Briefly, cells at
50–70% confluency were co-transfected with 0.4 g of pRSV-gal and
0.8 g of human WNT4 promoter/pGL2Basic. Cells were harvested
48 h after transfection, lysed in a passive lysis buffer (Promega), and
assayed for firefly luciferase and normalized for -galactosidase
(Galacto-Star, Tropix). Transfections were performed in replicates of
six on three separate occasions.
Immunohistochemistry—Immunohistochemisty for PAX2 was per-
formed on 4% paraformaldehyde-fixed, paraffin-embedded embryonic
mouse kidney tissues as described previously (6). Briefly, 7-m sections
were deparaffinized, rehydrated, and boiled twice for 5 min in 10 mM
citrate buffer, pH 7.0. Endogenous peroxidase activity was quenched
using 3% H2O2 in methanol for 30 min at room temperature. After a
30-min blocking step with horse serum, sections were incubated with
1:50 dilution of polyclonal rabbit anti-PAX2 antibody (Zymed Labora-
tories Inc., San Francisco, CA) overnight at 4 °C, followed by staining
with the Vectastain ABC universal kit (Vector Laboratories, Burl-
ingame,CA) as described by themanufacturer. Sectionswere then incu-
bated with diaminobutyric acid reagent (Vector Laboratories). Sections
were counterstainedwithMayer’s hematoxylin (Sigma) for 3min, dehy-
drated, and mounted with Permount (Fisher).
Immunofluorescent staining was performed on 14-m frozen sec-
tions of embryonic mouse kidney. Briefly, sections were rinsed in PBS
for 10 min and fixed in ice-cold acetone for 10 min. Sections were
blocked with horse serum for 1 h at room temperature and then incu-
bated with a 1:50 dilution of primary polyclonal rabbit anti-PAX2 anti-
body (Zymed Laboratories Inc.) overnight at 4 °C. Sections were
exposed for 1 h at room temperature to secondary anti-rabbit IgG
(1:200) conjugated with Texas Red as per the manufacturer’s recom-
mendations (Vector Laboratories). Sections were then stained with a
1:200 dilution of fluorescein-labeled Lotus tetragonolobus lectin (Vector
Laboratories) overnight at 4 °C and mounted with aqueous gel mount
(Sigma).
To confirm the proximal tubule origin of JTC12 cells, monolayers
were cultured on chamber slides in Dulbecco’s modified Eagle’s
medium (Invitrogen) supplemented with 10% serum and 1% penicillin/
streptomycin (Invitrogen) until they reached 60% confluence. The cells
were fixed for 10 min on ice in 4% paraformaldehyde. After several
washes in PBS, cells were incubated with fluorescein-labeled L. tet-
ragonolobus lectin (Vector Laboratories) for 30min at 37 °C. Slides were
then rinsed in PBS and mounted with aqueous gel mount (Sigma).
In Situ Hybridization—Mouse Wnt4 cDNA (851–1275 bp) sub-
cloned into PGEM7zf vector was kindly provided by Dr. McMahon
(Harvard University). The Wnt4 antisense and sense probes (424 bp)
were generated by linearizing the vector with BamHI and XbaI restric-
tion endonucleases and Sp6 and T7 promoters, respectively. 0.5 g (1
l) of the plasmid template was combined with 125 Ci of 35S-labeled
-UTP (1320 Ci/mmol; PerkinElmer Life Sciences), 1 l of 10 tran-
scription buffer (100mMNaCl, 400mMTris, pH 7.5, 60mMMgCl2, 100
mM DTT, 40 mM spermidine), 1.5 l of 3.3 mM of ATP, GTP, and CTP
mixture (Amersham Biosciences), 1 l of 100 mM DTT, and 0.25 units
of RNAguard (Roche Applied Science). 20 units of the appropriate
enzyme was added, and the final mixture was incubated for 1 h at 37 °C.
DNA template was digested with 2.5 units of DNase (Roche Applied
Science) at 37 °C for 15min. The cRNA probes were purified by ethanol
precipitation in the presence of carrier yeast RNAandwashed two times
with 70% EtOH. Integrity of probe was checked on a 4% denaturing gel.
5  104 cpm/l of the hybridization buffer in a volume of 100 l was
used for in situ hybridization on each slide.
E14.5 Pax21Neu wild type and heterozygous mouse embryos were
fixed in 4% paraformaldehyde and embedded in paraffin. Five-micron
sections were mounted on Frost-Plus glass slides (Fisher), deparaf-
finized, rehydrated, and incubated with 5 g/ml of proteinase K fol-
lowed by three rinses in PBS. Slides were incubated for 2–4 h at room
temperature in 100 l of prehybridization buffer (4 SET, 1 Den-
hardt’s, 0.5 mg/ml salmon sperm DNA, 0,6 mg/ml yeast RNA) mixed
with 50% formamide followed by overnight incubation at 52.5 °C in 100
l of 50% formamide and 1 hybridization buffer (4 SET, 1 Den-
hardt’s solution, 100 g/ml single-stranded DNA, 100 g/ml yeast
RNA, 10%dextran sulfate) combinedwith the labeled probe. Slideswere
washed twice in 2 SSC, 5 mM DTT at room temperature for 10 min
and twice in the same buffer at 50 °C followed by two washes in 50%
formamide, 1 SSC, 10mMDTT at 55 °C and then at 62 °C. Slides were
rinsed three times for 10 min in 0.5 SSC at room temperature and
treated with 20 g/ml RNase A in 3.5 SSC at 37 °C. They were then
rinsed four times in 3.5 SSC and three times at room temperature in
2 SSC, followed by dehydration in ethanol. Slides were dipped in the
photographic emulsion, exposed, counterstained with hematoxylin-eo-
sin, and photographed.
Electrophoretic Mobility Shift Assays (EMSAs)—Probes for EMSAs
were prepared from synthetically generated oligonucleotides. The
sequences of the probes are as below. Putative sense (A and B) and
antisense (C) core recognition nucleotides are double-underlined.
Mutations were created in conserved core PAX2 recognition nucleo-
Pax2 ActivatesWnt4
12706 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 18•MAY 5, 2006
 at UQ Library on October 10, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
tides for sites A, B, and C; these are shown in boldface. For A, 5-TCG-
GCGGCGCGCAGCCAGGCGTGCCTGGAG-3; for B, 5-AGAGC-
CCCCCGTCACTCTTGAAAACATCCT-3; and for C, 5-CAGT-
ACGTACTTCCTAGATTTGTTGCAACGATTGAATGA-3; for A
(mut), 5-TCGGCGGCGCGAAGCCAGGCGTGCCTGGAG-3; for B
(mut), 5-AGAGCCCCCCGTAACTCTTTAAAACATCCT-3; and
for C (mut), 5-CAGTACGTACTTCCTAGATTTGTTGAAACGAT-
TTAATGA-3. Synthetic oligonucleotide probes to the WNT4
promoter region were labeled by back filling with the Klenow fragment
of DNA polymerase I using [-32P]dCTP (3000 Ci/mmol; PerkinElmer
Life Sciences). The Pax2 proteins were synthesized using a T7-coupled
transcription/translation reticulocyte lysate system (Promega). The in
vitro translated products were incubated with 32P-labeled probes at
room temperature for 15 min in a solution containing 4% Ficoll, 1 mM
EDTA, pH 8.0, 10mMHEPES, pH 7.9, 1mM dithiothreitol (DTT), and 1
g of poly[(dIdC)(dIdC)]. In some reactions, the protein was also prein-
cubated with the 1 g of anti-PAX-2/5/8(N-19) antibody (catalog
number sc-7747; Santa Cruz Biotechnology) for 20 min at room
temperature and then incubated with the radiolabeled probe for 20min
at room temperature. For competition experiments, reaction mixtures
were preincubated for 15 min at room temperature with unlabeled oli-
gonucleotide prior to the addition of radiolabeled probes. Following the
binding step, reaction mixtures were electrophoresed on a 6% poly-
acrylamide gel (acrylamide/bisacrylamide ratio, 29:1) in 0.25 TBE
buffer (22.25mMTrisHCl, 22.25mM boric acid, and 1mM EDTA) at 90
V at room temperature. The gels were dried and exposed to Kodak
X-Omat film at room temperature.
Stable Transfection of JTC12 Cells and Western Immunoblotting—
Subconfluent JTC12 cells were transfected with a PAX2 expression vec-
tor, pCDNA3.1/PAX2, or with an empty vector without the PAX2
insert, using the lipophilic transfection agent FuGENETM 6 (Roche
Applied Science). After 48 h, cells were then selected in medium con-
taining 400 g/ml G418 for 2–3 weeks; surviving colonies were pooled.
Protein inwhole cell extractswere resolved on 10%SDS-polyacrylamide
gels, electroblotted onto Hybond ECL membrane (Amersham Bio-
sciences), and probed with rabbit anti-PAX2 polyclonal antibody (1
g/ml) (catalog number 71-6000, ZymedLaboratories Inc.), followed by
incubation with horseradish peroxidase-conjugated goat anti-rabbit
IgG (1:10,000; Bio-Rad). To visualize protein bands, blots were incu-
bated in Western Lightning Chemiluminescence Reagent Plus accord-
ing to the manufacturer’s instructions (PerkinElmer Life Sciences) and
exposed to Kodak X-Omat film. Band intensity was quantified and nor-
malized for GAPDH.
RNA Isolation—Three litters of E15.5 Pax21Neumice were sacrificed,
and total RNA was extracted from each pair of kidneys. Genotypes of
the Pax21Neu pups and their wild type littermates were identified as
described previously (Clark Electromedical Instruments). Total RNA
was isolated from kidney lysates with RNeasy columns (Qiagen, Valen-
cia, CA) according to the manufacturer’s directions. RNA was treated
with DNase while bound to the RNeasy column.
Real Time RT-PCR—All real time RT-PCRs were carried out using
theMx4000Multiplex Quantitative PCR System (Stratagene). We used
the Qiagen QuantiTectTM SYBR Green RT-PCR method for quanti-
tative, real time one-step RT-PCR. Following reverse transcription with
universal primers, PCR amplifications were performed using the rec-
ommended buffer supplied by the manufacturer. Primers included the
following: 5Wnt4(sense), ACCTGGAAGTCATGGACTCG; 3Wnt4-
(antisense), TCAGAGCATCCTGACCACTG. Each 25-l PCR conta-
ined cDNA, forward and reverse primers, and the passive reference dye
(ROX) to normalize the SYBR Green/double-stranded DNA complex
signal during analysis to correct for well-to-well variations. Triplicate or
quadruplicate reactions were performed for each template amount.
DNA standard templatewas replacedwithwater in all no-template con-
trols.We performed simultaneous real timeRT-PCRwith glyceraldehy-
de-3-phosphate dehydrogenase (Gapdh). All N-methyl-D-aspartic acid
values were normalized forGapdh. PCR cycling conditions were as fol-
lows: initial denaturation at 95 °C for 15 min according to manufactu-
rer’s recommendations, followed by 35 cycles of 94 °C for 1 min, 1 min
of annealing (annealing temperature adapted for specific primer set
used), and 1 min/kb extension at 72 °C. The identities of the PCR pro-
ducts were examined by melting curve analysis on the Mx4000 and by
agarose gel electrophoresis. Data analysis was performed using the
Mx4000 software. The calculated threshold (CT) was determined for all
samples and defined as the amount of theWnt4 gene in relation to the
reference gene Gapdh. All results are displayed as fold induction of
target gene mRNA expression as determined by the CT method.
Briefly, CT indicates the difference between the number of cycles
necessary to detect the PCR products of Wnt4 and the reference gene
Gapdh.
RESULTS
PAX2 Is Expressed in the Distal S-shaped Body and Persists in Fetal
Proximal Tubule—Previous investigators have demonstrated Pax2
mRNA expression in induced mesenchymal cells as they cluster at the
tip of each ureteric bud branch (2). Our immunohistochemical studies
show that PAX2 protein expression is sustained in tubular cells of the
distal loop of S-shaped bodies (Fig. 1A). However, PAX2 protein is con-
spicuously absent in epithelial cells at the proximal loop of the S-shaped
body, which will give rise to podocytes of the primitive glomerulus (Fig.
1A). PAX2 expression is evident in maturing tubules that stain for the
differentiated proximal tubule marker, L. tetragonolobus lectin (Fig. 1,
B–D). The JTC12 cell line, derived from simian renal proximal tubule,
also exhibits immunofluorescent staining for L. tetragonolobus lectin
(Fig. 1C) andwas used for the in vitro studies of PAX2 andWNT4 below.
FIGURE 1. PAX2 protein expression in fetal mouse kidney. A, PAX2 protein was iden-
tified by immunohistochemistry in the distal portion of the S-shaped bodies (arrow-
heads) of E15.5 fetal mouse kidneys. B, in frozen sections of E16.5 fetal mouse kidney,
PAX2 protein was evident in epithelial cells of developing tubules. Anti-PAX2 antibody
was detected by immunofluorescent staining with Texas Red-labeled second antibody.
C, simian JTC12 cells are derived from proximal tubules and exhibit staining for the
fluorescein-tagged proximal tubule marker, L. tetragonolobus lectin as do the PAX2-
positive cells of fetal mouse kidney (D).
Pax2 ActivatesWnt4
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PAX2 Activates the WNT4 Promoter in Vitro—To determine
whether PAX2 activates WNT4 promoter activity in vitro, a 10.7-kb
5-flanking sequence of the human WNT4 gene (15) was cloned into a
luciferase reporter vector and co-transfected with a full-length human
PAX2b expression vector into cultured JTC12 cells (Fig. 2). Luciferase
activity in cell extracts was assayed after 48 h. In the presence of PAX2b,
transcriptional activity of the 10.7-kb WNT4 promoter was increased
5-fold.
Description of Putative PAX2-binding Sites in the WNT4 Promoter—
To determine whether the WNT4 promoter contains plausible PAX2-
binding sites, we screened the 10.7-kb 5-flanking sequence of the
human WNT4 gene (15) with MatInspector software. The recognition
motif for PAX2 has been studied by others and appears to vary signifi-
cantly from gene target to gene target. Nevertheless, a consensus
sequence consisting of about 11 core nucleotides spaced over a stretch
of 25 bp has been proposed (4). Of 11 putative sites with partial homol-
ogy to this consensus sequence, only 5 were subsequently shown to
specifically bind PAX2 protein. The first putative PAX2-binding
motif (motif A in Fig. 3A) was identified close (461 to 435 in
sense orientation) to the transcriptional start site. It contained only 7
of the 11 core nucleotides of the PAX2 consensus sequence but was
selected for study because it also exhibited homology with the
“PAX5” recognition sites.
A second (motif B1 at2428 to2405) and third (motif C1 at2460
to2581) putative PAX2 recognition sequence were identified further
upstream, positioned fairly closely together and in sense and antisense
orientations, respectively. These two motifs contained 9 (motif B1) and
6 (motif C1) nucleotides of the PAX2 consensus sequence, respectively.
Most interestingly, motifs C1 and B1 lie within a 0.66-kb cassette of
DNA (5331 to 4672) that was completely duplicated further
FIGURE 2. PAX2 activates transcriptional activity of the human WNT4 promoter.
JTC12 cells were transiently co-transfectedwith a pGL2 luciferase reporter vector driven
by a 10.7-kb fragment of the humanWNT4 gene 5-flanking sequence and amammalian
expression vector containing the full-length human PAX2 cDNA. Luciferase activity was
assayed after 48 h and expressed as a percent of basal promoter activity. Empty pGL2
vector luciferase activitywasone-thirdof that in thepresenceof aWNT4promoter. In the
presence of exogenous PAX2, basal promoter activity was stimulated 5.4-fold.
FIGURE 3. Putative PAX2-binding sites in the
human WNT4 promoter. A and B, the 10.6-kb
5-flanking sequence of the human WNT4 gene
was analyzed with MatInspector software for pos-
sible PAX2-binding motifs. Three of 11 potential
PAX2 recognition motifs were subsequently
shown to bind PAX2 protein in gel shift assays.
Twomotifs (B1 andC1) liewithin a 660-bp cassette
duplicated further upstream. C, the three putative
unique PAX2-binding motifs are compared with
other published sequences.
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upstream (7563 to 6904) (Fig. 3A). Thus, two additional putative
PAX2 motifs (B2 and C2) were identified close together lying on oppo-
site DNA strands, but these were duplicates of sites in the downstream
cassette. The three unique putative PAX2-binding motifs and sur-
rounding nucleotide sequences are listed in Fig. 3B and compared with
PAX2 recognition motifs reported by others (Fig. 3C).
EMSA—To determine whether the three putative recognition motifs
exhibited specific high affinity PAX2 binding, a series of gel shift experi-
FIGURE 4. Electrophoretic mobility shift assays for PAX2 binding to putative recognition motifs in the WNT4 promoter. A, PAX2 protein forms a unique complex with
radiolabeled probeA (lane 1), probe B (lane 5), or probeC (lane 8) that disappear in the presence of anti-PAX2 antibody (lanes 2, 6, and 9, respectively). B, the radiolabeled PAX2-probe
A complex is competed out by progressively increasing amounts of cold unlabeled probe A (lanes 2–7). Mutation of a single cytosine to an adenine within the putative PAX2
recognitionmotif significantlydiminishes thePAX2-probeband (lanes 8and9).C, the radiolabeledPAX2-probeBcomplex is competedoutby increasingamountsof unlabeledprobe
B (lanes 2–7). For the mutation of two core nucleotides of the putative PAX2 recognition motif in probe B, no complex formation is seen (lane 8). D, the radiolabeled PAX2-Probe C
complex is competed out by increasing amounts of unlabeled probe C (lanes 2–6). Mutation of two core nucleotides in probe C eliminates complex formation (lane 8). E, although
complex inhibition by unlabeledwild type oligonucleotides was evident at 25-fold excess (probe A), 50-fold excess (probe B), and 100-fold excess (probe C) (lane 4 (B), lane 4 (C), and
lane 5 (D), respectively), mutant unlabeled oligonucleotides were ineffective competitors at similar molar ranges. Protein-DNA complexes were resolved on nondenaturing 6%
polyacrylamidegels electrophoresedat roomtemperature in 0.25TBE. Complexeswere visualizedbydrying thegel andexposing to film (EastmanKodakCo.) at roomtemperature.
The positions of free probe and protein-DNA complexes are indicated.
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ments was performed with radiolabeled oligonucleotides containing the
A–C sequences and in vitro translated PAX2 protein. Incubation of PAX2
protein with each radiolabeled probe resulted in single protein-DNA com-
plexes seen as band shifts in Fig. 4A, lanes 1, 5, and 8. The complex disap-
peared in the presence of PAX2 antibody (Fig. 4A, lanes 2, 6, and 9) but not
nonimmune serum (data not shown). The specificity of Pax2 binding was
examined in competition assays with increasing amounts of excess unla-
beled wild type oligonucleotides A–C (Fig. 4, B–D) and mutant oligonu-
cleotides A (mut), B (mut), and C (mut) (Fig. 4E). Binding of PAX2 to
probes A–C was competed out by increasing amounts of unlabeled wild
type oligonucleotides A–C (Fig. 4, B–D). Competition was evident at
25-fold excess (probe A), 50-fold excess (probe B), and 100-fold excess
(probeC)unlabeledwild typeoligonucleotide.EMSAswerealsoperformed
with PAX2 protein andmutated oligonucleotides A (mut), B (mut), and C
(mut), as probes. Mutation of a single core nucleotide in the putative rec-
ognitionmotif of probeAsignificantly reduces complexband intensity (Fig.
4B, lanes9versus2).WhencorenucleotidesofmotifBandCweremutated,
complex formation was completely abrogated (Fig. 4, C, lanes 8 versus 2,
and D, lanes 8 versus 2). Similarly, mutant cold oligonucleotides were
unable to inhibit complex formation in the same molar range as the unla-
beled wild type oligonucleotide competitors (Fig. 4E). Thus, PAX2 recog-
nizes each of the three sites in sequence-specific fashion.
PAX2 Activates Endogenous WNT4 in JTC12 Cells—JTC12 cells are
derived from themonkey proximal tubule lineage and express the prox-
imal tubular marker, L. tetragonolobus lectin. The cells express modest
levels of endogenous PAX2, identifiable by Western immunoblotting
(Fig. 5A). To examine the effect of PAX2 on endogenousWNT4 expres-
sion, JTC12 cells were stably transfected with a cytomegalovirus-driven
human PAX2 expression vector and selected in neomycin-containing
culture medium. Stable transfectants were isolated and re-assessed for
PAX2 protein level byWestern immunoblotting. As seen in Fig. 5A, the
JTC12/PAX2 stable transfectants expressed about five times as much
PAX2 protein as the parent cell line.
EndogenousWNT4mRNA levels were measured in control (parent)
JTC12 cells and in the stable JTC12/PAX2 transfectants by real time
RT-PCR, normalizing samples for Gapdh mRNA amount. As seen in
Fig. 5B, WNT4 mRNA levels were about 7-fold higher in the JTC12/
PAX2 transfectants compared with control cells.
WNT4 Expression Is Reduced in the Pax21Neu Mutant Mouse—In
previous studies we demonstrated that fetal kidneys from Pax21Neu het-
erozygotes have reduced PAX2 protein and moderately severe renal
hypoplasia, although the architecture of individual nephrons is rela-
tively normal (6). To determine whether the in vitro evidence ofWNT4
regulation by PAX2 reflects an important molecular pathway for mam-
malian kidney development in vivo, we assessed endogenous Wnt4
expression in E15 fetal kidney of heterozygous Pax21Neu mutant mice
and their wild type littermates. Heterozygous male Pax21Neu C3Hmice
were crossed with wild type C3H females. E15 embryos were genotyped
as described previously (8), and fetal kidneys were isolated and proc-
essed for in situ hybridization studies with aWnt4 riboprobe. As seen in
Fig. 6, A and B, Wnt4 mRNA expression is abundant but is highly
restricted to the condensing mesenchyme adjacent to ureteric bud
branch tips (arrows) in normal fetal kidney. In contrast, theWnt4 signal
is barely detectable in condensing mesenchyme of Pax21Neu fetal kid-
neys (Fig. 6, C and D). Similarly, in situ hybridization studies were per-
formed for Eya1, another transcription factor expressed in early
induced renalmesenchyme; Eya1mRNAexpressionwas comparable in
Pax21Neu and wild type E15.5 kidneys (data not shown).
Wnt4mRNAwas quantified in mutant and wild type fetal kidneys by
real time RT-PCR and normalized for GapdhmRNA in the same sam-
ples. In keeping with our in situ hybridization studies, relative Wnt4
mRNA in E15.5 Pax21Neumutant kidney was only 40% of that in kidneys
from wild type littermates (Fig. 7).
DISCUSSION
Potential Functions of the PAX2/WNT4 Pathway during
Nephrogenesis—PAX2 plays a central role in the caudal descent of the
nephric duct, the emergence of ureteric buds, and the subsequent
branchingmorphogenesis of the collecting system. PAX2mRNA is also
abundant in metanephric mesenchymal cells as they cluster at UB tips
(2), and its function there is as yet unknown.Our immunohistochemical
studies show that PAX2 protein expression is sustained beyond this
stage. It appears in distal portions of the developing S-shaped body as
FIGURE5.A,monkey kidneyproximal tubular cell line (JTC12)was stably transfectedwith
human PAX2 cDNA, increasing PAX2 protein expression above themodest endogenous
level. B,up-regulation ofWNT4mRNA in JTC12 cells overexpressing PAX2was confirmed
by quantitative real time RT-PCR and normalized for GapdhmRNA.
FIGURE 6. In situ hybridization analysis of Wnt4 expression in fetal wild type and
heterozygous Pax21Neu kidneys. Sections of E15 wild type and Pax21Neu mutant
embryoswere hybridized to amurineWnt4 riboprobe. B andD,bright field.A andC,dark
field. Magnification 200. Condensing mesenchyme (CM) shows intense silver grain
deposition in wild type kidney (A and B) but not in heterozygous mutant kidneys (C and
D). Metanephric blastema (MB), ureteric bud (UB), and glomeruli (G) are negative for
Wnt4 expression in both wild type and Pax21Neu kidneys.
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differentiation proceeds and is still evident in the early fetal proximal
tubule. Apparently, PAX2 is involved both in the process whereby met-
anephric mesenchyme is transformed into polarized epithelium and/or
in the maturation of the proximal convoluted tubule as it undergoes
terminal differentiation.
Previous reports suggest that these events are also critically depend-
ent on expression of the secreted growth factor, WNT4. In mice with
homozygous inactivation of the Wnt4 gene, the UB successfully con-
tactsmetanephricmesenchyme and inducesmesenchymal cells to clus-
ter and express PAX2 at its tips (10, 17). However, subsequent progres-
sion to the S-shaped body stage does not occur (10, 17). This
observation places PAX2 temporally upstream of WNT4 during this
process.Our studies demonstrate reducedWnt4mRNA in thePax21Neu
mouse and indicate that Pax2 is functionally upstream of WNT4
expression in the developmental cascade as well.
There is some evidence that WNT4 is involved in cell movement
during development. Acting through the frizzled3 receptor, WNT4
guides murine commissural axons as they cross the midline (18). In
Drosophila, WNT4 has been implicated in cell movements requiring
disassembly of focal adhesion complexes; Drosophila WNT4 regulates
focal adhesion kinase during ovarian morphogenesis through the non-
canonical protein kinase C pathway (19). Conceivably,WNT4 signaling
via this pathway might play a role in the spectacular serpentine growth
of the S-shaped body and proximal convoluted tubule.
On the other hand, there is also evidence thatWNT4may have a set of
effects mediated through the canonical -catenin signaling pathway (13).
This intracellular pathway responds to WNT activation of heterodimeric
frizzled/LRP6 receptors at the surface of target cells (20). Activated canon-
ical receptors recruit DSH and other partners to suppress degradation of
-catenin and facilitate its transfer to the nucleus. There, -catenin com-
bines with transcription factor partners of the TCF/LEF family to regulate
expressionof target genes (21). Rodcell production in thedeveloping retina
is promoted by canonical WNT4/FZD4/LRP6 signaling (22). Canonical
WNT4 signaling drives synovial joint development (23) and mediates the
effects of estrogen on uterine growth (24).
High levels of canonical -catenin signaling activity have been iden-
tified in both the distal S-shaped body and tips of the ureteric bud during
mouse kidney development (25, 26). Thus, PAX2-activated WNT4
expression might drive autocrine canonical signaling during formation
of the S-shaped body. There is the interesting possibility that WNT4
could also provide a paracrine signal to the adjacent ureteric bud tip.
WNT4 is reported to activate the canonical -catenin signaling path-
way in cultured Madin-Darby canine kidney cells derived from the
canineUB lineage (13).WNT4 has been implicated in side-branching of
mammary ductal cells during breast development (27).Wnt4 knock-out
mouse fail to form S-shaped bodies, but this is accompanied by an
abrupt halt to any further UB branching (10).
PAX2 Binding to NovelMotifs within theWNT4Gene Promoter—We
demonstrate that PAX2 directly activates transcriptional activity of the
5-flanking sequence of the human WNT4 gene, containing several
unique PAX2 recognitionmotifs. A novel 26-bp sequence (labeledmotif
A in Fig. 1A) about 0.45 kb upstream of the transcriptional start site
showed homology both to the consensus PAX2 recognition motif pro-
posed by Brophy et al. (4) and to the PAX5 motif used in MatInspector
software. Pax2, -5, and -8 form a subgroup within the Pax gene family
based on domain structure; crossover between PAX2 andPAX5binding
sequences has been noted in other gene targets (16). Two other motifs
within the 5-flanking sequence of the human WNT4 gene (labeled
motifs B and C in Fig. 1A) were more similar to the published PAX2
consensus recognition motif (4). Most interestingly, PAX2-binding
motifs B1 and C1 were located in close proximity to each other oriented
on opposite (sense and antisense) DNA strands and lie within a 0.66-kb
cassette (5331 to 4672) that was completely duplicated at an
upstream site (7563 to 6904) in the 5-flanking sequence. Possibly, this
duplication event reflects the importance of these PAX2 motifs and/or
other elements of the cassette in regulating WNT4 expression.
It is unclear why theWNT4 gene should contain several slightly dif-
ferent recognition motifs for PAX2, yet each of the motifs (A, B1/B2, or
C1/C2) exhibited specific high affinity binding to PAX2 protein in
EMSAs. In each case, the PAX2-probe complex was sensitive to anti-
PAX2 antibody, mutation of core PAX2 recognition motif base pairs,
and addition of cold-unlabeled motif DNA. Clearly, other transcription
factors could be involved in determining the highly restricted expres-
sion of WNT4 in mesenchymally derived portions of the renal tubule;
PAX2 is expressed at other sites in the developing kidney (e.g. ureteric
bud) where WNT4 expression is absent. Presumably, additional tran-
scription factors are required to achieve a combinatorial specificity with
PAX2 and account for the highly restricted pattern of WNT4 expres-
sion. The variability of PAX2 recognition sequences might reflect the
molecular complexity of this regulation.
PAX2 Activates EndogenousWNT4Gene in Vivo—The in vitro inter-
actions between PAX2 and the WNT4 promoter are clearly relevant
during in vivo renal development. EndogenousWnt4mRNAexpression
was significantly reduced in the mesenchymal condensates/S-shaped
bodies of heterozygous mutant Pax21Neu mouse fetal kidneys. Interest-
ingly, heterozygous mutant Pax21Neu fetal mouse kidneys are hypoplas-
tic (6), but the reduction in WNT4 expression is not sufficient to pre-
vent formation of some normal appearing S-shaped bodies during
development. This is not surprising, however, because normal appear-
ing S-shaped bodies were also noted in fetal kidneys of heterozygous
Wnt4 knock-out mice. Thus, the developmental cascade allowing dif-
ferentiation of S-shaped bodies seems to require only a modest level of
PAX2 and WNT4. Below some minimal threshold, however (as in
homozygousWnt4 knock-outmice), S-shaped body formation does not
occur.
Conclusion—During renal development, PAX2 is expressed in the
distal portion of the emerging S-shaped body and early proximal tubule.
We suggest that it binds directly to novel response elements in the
WNT4 promoter, activating transcription during the mesenchyme to
epithelium transition. WNT4 expression continues in the S-shaped
body and early proximal tubule and could influence its serpentine
growth and terminal differentiation. Conceivably, PAX2 activation of
WNT4 could initiate a paracrine feedback signal to ureteric bud cells
and promote further rounds of branching nephrogenesis.
FIGURE 7. Real time RT-PCR estimation ofWnt4mRNAnormalized forGapdhmRNA
in the same samples from wild type E15. Five fetal mouse kidney and heterozygous
Pax21Neu littermates are shown.
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